{"id":44948,"date":"2022-06-10T14:01:36","date_gmt":"2022-06-10T12:01:36","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-diagnostics-partnering-terms-and-agreements-report-directory-2015-2022-access-to-3200-deals-signed-by-the-worlds-leading-biopharma-companies-researchandmarkets-com\/"},"modified":"2022-06-10T14:01:36","modified_gmt":"2022-06-10T12:01:36","slug":"global-diagnostics-partnering-terms-and-agreements-report-directory-2015-2022-access-to-3200-deals-signed-by-the-worlds-leading-biopharma-companies-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-diagnostics-partnering-terms-and-agreements-report-directory-2015-2022-access-to-3200-deals-signed-by-the-worlds-leading-biopharma-companies-researchandmarkets-com\/","title":{"rendered":"Global Diagnostics Partnering Terms and Agreements Report\/Directory 2015-2022: Access to 3,200+ Deals Signed by the World&#8217;s Leading Biopharma Companies &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/2300224\/global_diagnostics_partnering_terms_and?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=nf6jgv&amp;utm_campaign=1712021+-+Global+Diagnostics+Partnering+Terms+and+Agreements+Report%2FDirectory+2015-2022%3A+Access+to+3%2C200%2B+Deals+Signed+by+the+World%27s+Leading+Biopharma+Companies&amp;utm_exec=chdo54prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Global Diagnostics Partnering Terms and Agreements 2015-2022&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220610005282\/en\/1482996\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220610005282\/en\/1482996\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThe Global Diagnostics Partnering Terms and Agreements 2015-2022 report provides comprehensive access to available deals and contract documents for over 3,200 Diagnostics deals.\n<\/p>\n<p>\nThe report provides a detailed understanding and analysis of how and why companies enter Diagnostics partnering deals. These deals tend to be multicomponent, starting with collaborative R&amp;D, and proceed to commercialization of outcomes.\n<\/p>\n<p>\nThis report provides details of the latest Diagnostics agreements announced in the life sciences since 2015.\n<\/p>\n<p>\nThe report takes the reader through a comprehensive review Diagnostics deal trends, key players, top deal values, as well as deal financials, allowing the understanding of how, why and under what terms, companies are entering Diagnostics partnering deals.\n<\/p>\n<p>\nThe report presents financial deal term values for Diagnostics deals, listing by headline value, upfront payments, milestone payments and royalties, enabling readers to analyse and benchmark the financial value of deals.\n<\/p>\n<p>\nThe middle section of the report explores the leading dealmakers in the Diagnostics partnering field; both the leading deal values and most active Diagnostics dealmaker companies are reported allowing the reader to see who is succeeding in this dynamic dealmaking market.\n<\/p>\n<p>\nOne of the key highlights of the report is that over 3,200 online deal records of actual Diagnostics deals, as disclosed by the deal parties, are included towards the end of the report in a directory format &#8211; by company A-Z, stage of development, deal type, therapy focus, and technology type &#8211; that is easy to reference. Each deal record in the report links via Weblink to an online version of the deal.\n<\/p>\n<p>\nIn addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners. Whilst many companies will be seeking details of the payment clauses, the devil is in the detail in terms of how payments are triggered &#8211; contract documents provide this insight where press releases and databases do not.\n<\/p>\n<p>\nA comprehensive series of appendices is provided organized by Diagnostics partnering company A-Z, stage of development, deal type, and therapy focus. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each deal on demand.\n<\/p>\n<p>\nThe report also includes numerous tables and figures that illustrate the trends and activities in Diagnostics partnering and dealmaking since 2015.\n<\/p>\n<p>\nIn conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Diagnostics technologies and products.\n<\/p>\n<p>\n<strong>This report provides details of the latest diagnostics agreements announced in the healthcare sectors, covering:<\/strong>\n<\/p>\n<ul>\n<li>\nCompanion Diagnostics\n<\/li>\n<li>\nImaging\n<\/li>\n<li>\nCT\n<\/li>\n<li>\nEndoscope\n<\/li>\n<li>\nMolecular and nuclear\n<\/li>\n<li>\nMRI\n<\/li>\n<li>\nUltrasound\n<\/li>\n<li>\nX-ray\n<\/li>\n<li>\nPET\n<\/li>\n<li>\nSPECT\n<\/li>\n<li>\nAngiography\n<\/li>\n<li>\nFluroscopy\n<\/li>\n<li>\nMammography\n<\/li>\n<li>\nIn vitro diagnostics\n<\/li>\n<li>\nMolecular diagnostics\n<\/li>\n<li>\nPrognostics\n<\/li>\n<li>\nTheranostics\n<\/li>\n<\/ul>\n<p>\n<strong>Key benefits<\/strong>\n<\/p>\n<p>\n<strong>Global Diagnostics Partnering Terms and Agreements 2015-2022 provides the reader with the following key benefits:<\/strong>\n<\/p>\n<ul>\n<li>\nIn-depth understanding of Diagnostics deal trends since 2015\n<\/li>\n<li>\nAccess to headline, upfront, milestone and royalty data\n<\/li>\n<li>\nDetailed access to actual Diagnostics contracts entered into by leading biopharma companies\n<\/li>\n<li>\nIdentify most active Diagnostics dealmakers since 2015\n<\/li>\n<li>\nInsight into terms included in a Diagnostics partnering agreement, with real world examples\n<\/li>\n<li>\nUnderstand the key deal terms companies have agreed in previous deals\n<\/li>\n<li>\nUndertake due diligence to assess suitability of your proposed deal terms for partner companies\n<\/li>\n<\/ul>\n<p>\n<strong>In Global Diagnostics Partnering Terms and Agreements 2015-2022, the available deals are listed by:<\/strong>\n<\/p>\n<ul>\n<li>\nCompany A-Z\n<\/li>\n<li>\nHeadline value\n<\/li>\n<li>\nStage of development at signing\n<\/li>\n<li>\nDeal component type\n<\/li>\n<li>\nSpecific therapy target\n<\/li>\n<li>\nTechnology type\n<\/li>\n<\/ul>\n<p>\n<strong>Analyzing actual contract agreements allows assessment of the following:<\/strong>\n<\/p>\n<ul>\n<li>\nWhat are the precise rights granted or optioned?\n<\/li>\n<li>\nWhat is actually granted by the agreement to the partner company?\n<\/li>\n<li>\nWhat exclusivity is granted?\n<\/li>\n<li>\nWhat is the payment structure for the deal?\n<\/li>\n<li>\nHow are sales and payments audited?\n<\/li>\n<li>\nWhat is the deal term?\n<\/li>\n<li>\nHow are the key terms of the agreement defined?\n<\/li>\n<li>\nHow are IPRs handled and owned?\n<\/li>\n<li>\nWho is responsible for commercialization?\n<\/li>\n<li>\nWho is responsible for development, supply, and manufacture?\n<\/li>\n<li>\nHow is confidentiality and publication managed?\n<\/li>\n<li>\nHow are disputes to be resolved?\n<\/li>\n<li>\nUnder what conditions can the deal be terminated?\n<\/li>\n<li>\nWhat happens when there is a change of ownership?\n<\/li>\n<li>\nWhat sublicensing and subcontracting provisions have been agreed?\n<\/li>\n<li>\nWhich boilerplate clauses does the company insist upon?\n<\/li>\n<li>\nWhich boilerplate clauses appear to differ from partner to partner or deal type to deal type?\n<\/li>\n<li>\nWhich jurisdiction does the company insist upon for agreement law?\n<\/li>\n<\/ul>\n<p>\n<strong>Key Topics Covered:<\/strong>\n<\/p>\n<p>\n<strong>Executive Summary<\/strong>\n<\/p>\n<p>\n<strong>Chapter 1 &#8211; Introduction<\/strong>\n<\/p>\n<p>\n<strong>Chapter 2 &#8211; Trends in Diagnostics dealmaking<\/strong>\n<\/p>\n<p>\n2.1. Introduction\n<\/p>\n<p>\n2.2. Diagnostics partnering over the years\n<\/p>\n<p>\n2.3. Most active Diagnostics dealmakers\n<\/p>\n<p>\n2.4. Diagnostics partnering by deal type\n<\/p>\n<p>\n2.5. Diagnostics partnering by therapy area\n<\/p>\n<p>\n2.6. Deal terms for Diagnostics partnering\n<\/p>\n<p>\n2.6.1 Diagnostics partnering headline values\n<\/p>\n<p>\n2.6.2 Diagnostics deal upfront payments\n<\/p>\n<p>\n2.6.3 Diagnostics deal milestone payments\n<\/p>\n<p>\n2.6.4 Diagnostics royalty rates\n<\/p>\n<p>\n<strong>Chapter 3 &#8211; Leading Diagnostics deals<\/strong>\n<\/p>\n<p>\n3.1. Introduction\n<\/p>\n<p>\n3.2. Top Diagnostics deals by value\n<\/p>\n<p>\n<strong>Chapter 4 &#8211; Most active Diagnostics dealmakers<\/strong>\n<\/p>\n<p>\n4.1. Introduction\n<\/p>\n<p>\n4.2. Most active Diagnostics dealmakers\n<\/p>\n<p>\n4.3. Most active Diagnostics partnering company profiles\n<\/p>\n<p>\n<strong>Chapter 5 &#8211; Diagnostics contracts dealmaking directory<\/strong>\n<\/p>\n<p>\n5.1. Introduction\n<\/p>\n<p>\n5.2. Diagnostics contracts dealmaking directory\n<\/p>\n<p>\n<strong>Chapter 6 &#8211; Diagnostics dealmaking by technology type<\/strong>\n<\/p>\n<p>\n<strong>Appendices<\/strong>\n<\/p>\n<p>\nAppendix 1 &#8211; Diagnostics deals by company A-Z\n<\/p>\n<p>\nAppendix 2 &#8211; Diagnostics deals by stage of development\n<\/p>\n<ul>\n<li>\nDiscovery\n<\/li>\n<li>\nPreclinical\n<\/li>\n<li>\nPhase I\n<\/li>\n<li>\nPhase II\n<\/li>\n<li>\nPhase III\n<\/li>\n<li>\nRegulatory\n<\/li>\n<li>\nMarketed\n<\/li>\n<li>\nFormulation\n<\/li>\n<\/ul>\n<p>\nAppendix 3 &#8211; Diagnostics deals by deal type\n<\/p>\n<ul>\n<li>\nAsset purchase\n<\/li>\n<li>\nAssignment\n<\/li>\n<li>\nBigpharma outlicensing\n<\/li>\n<li>\nCo-development\n<\/li>\n<li>\nCollaborative R&amp;D\n<\/li>\n<li>\nCo-market\n<\/li>\n<li>\nCo-promotion\n<\/li>\n<li>\nCRADA\n<\/li>\n<li>\nCross-licensing\n<\/li>\n<li>\nDevelopment\n<\/li>\n<li>\nDistribution\n<\/li>\n<li>\nEquity purchase\n<\/li>\n<li>\nEvaluation\n<\/li>\n<li>\nGrant\n<\/li>\n<li>\nJoint venture\n<\/li>\n<li>\nLicensing\n<\/li>\n<li>\nLitigation\n<\/li>\n<li>\nManufacturing\n<\/li>\n<li>\nMarketing\n<\/li>\n<li>\nMaterial transfer\n<\/li>\n<li>\nOption\n<\/li>\n<li>\nPromotion\n<\/li>\n<li>\nResearch\n<\/li>\n<li>\nSettlement\n<\/li>\n<li>\nSpin out\n<\/li>\n<li>\nSub-license\n<\/li>\n<li>\nSupply\n<\/li>\n<li>\nTechnology transfer\n<\/li>\n<li>\nTermination\n<\/li>\n<li>\nWarranty\n<\/li>\n<\/ul>\n<p>\nAppendix 4 &#8211; Diagnostics deals by therapy area\n<\/p>\n<p>\nAppendix 5 -Deal type definitions\n<\/p>\n<p>\nAppendix 6 &#8211; Further reading on dealmaking\n<\/p>\n<p>\n<strong>Companies Mentioned<\/strong>\n<\/p>\n<ul>\n<li>\nIBA\n<\/li>\n<li>\nIBM\n<\/li>\n<li>\niCAD\n<\/li>\n<li>\nIcon\n<\/li>\n<li>\nIDS\n<\/li>\n<li>\nIDx\n<\/li>\n<li>\nImbio\n<\/li>\n<li>\nImec\n<\/li>\n<li>\nIMI\n<\/li>\n<li>\nIMRIS\n<\/li>\n<li>\nIPMD\n<\/li>\n<li>\nIQ-AI\n<\/li>\n<li>\nITEL\n<\/li>\n<li>\nItem\n<\/li>\n<li>\nITOCO\n<\/li>\n<li>\nItus\n<\/li>\n<li>\nIXICO\n<\/li>\n<li>\nKEW\n<\/li>\n<li>\nKore\n<\/li>\n<li>\nLab21\n<\/li>\n<li>\nLGC\n<\/li>\n<li>\nImage Analysis\n<\/li>\n<li>\nGreat Basin Scientific\n<\/li>\n<li>\nCosmo Bio\n<\/li>\n<li>\nAnpac Bio-Medical Science\n<\/li>\n<li>\nAmCad BioMed\n<\/li>\n<li>\nCanon BioMedical\n<\/li>\n<li>\nCenix BioScience\n<\/li>\n<li>\nInGen BioSciences\n<\/li>\n<li>\nArray Biopharma\n<\/li>\n<li>\nBliss Biopharmaceutical\n<\/li>\n<li>\nAgena Bioscience\n<\/li>\n<li>\nCrown Bioscience\n<\/li>\n<li>\nAkers Biosciences\n<\/li>\n<li>\nAkoya Biosciences\n<\/li>\n<li>\nAlume Biosciences\n<\/li>\n<li>\nAnixa Biosciences\n<\/li>\n<li>\nArbor Biosciences\n<\/li>\n<\/ul>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/2300224\/global_diagnostics_partnering_terms_and?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=nf6jgv&amp;utm_campaign=1712021+-+Global+Diagnostics+Partnering+Terms+and+Agreements+Report%2FDirectory+2015-2022%3A+Access+to+3%2C200%2B+Deals+Signed+by+the+World%27s+Leading+Biopharma+Companies&amp;utm_exec=chdo54prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/87ph79<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;a&#x69;l&#x74;&#111;&#x3a;&#112;&#x72;&#101;s&#x73;&#64;&#x72;&#101;&#x73;&#101;&#x61;&#114;&#x63;&#104;a&#x6e;d&#x6d;&#97;&#x72;&#107;&#x65;&#116;s&#x2e;c&#x6f;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">&#x70;&#x72;&#101;s&#x73;&#x40;&#114;es&#x65;&#x61;&#114;c&#x68;&#x61;&#110;&#100;m&#x61;&#x72;&#107;e&#x74;&#x73;&#46;&#99;o&#x6d;<\/a><br \/>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Diagnostics Partnering Terms and Agreements 2015-2022&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The Global Diagnostics Partnering Terms and Agreements 2015-2022 report provides comprehensive access to available deals and contract documents for over 3,200 Diagnostics deals. The report provides a detailed understanding and analysis of how and why companies enter Diagnostics partnering &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/global-diagnostics-partnering-terms-and-agreements-report-directory-2015-2022-access-to-3200-deals-signed-by-the-worlds-leading-biopharma-companies-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-44948","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Global Diagnostics Partnering Terms and Agreements Report\/Directory 2015-2022: Access to 3,200+ Deals Signed by the World&#039;s Leading Biopharma Companies - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/global-diagnostics-partnering-terms-and-agreements-report-directory-2015-2022-access-to-3200-deals-signed-by-the-worlds-leading-biopharma-companies-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Global Diagnostics Partnering Terms and Agreements Report\/Directory 2015-2022: Access to 3,200+ Deals Signed by the World&#039;s Leading Biopharma Companies - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Diagnostics Partnering Terms and Agreements 2015-2022&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The Global Diagnostics Partnering Terms and Agreements 2015-2022 report provides comprehensive access to available deals and contract documents for over 3,200 Diagnostics deals. The report provides a detailed understanding and analysis of how and why companies enter Diagnostics partnering ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/global-diagnostics-partnering-terms-and-agreements-report-directory-2015-2022-access-to-3200-deals-signed-by-the-worlds-leading-biopharma-companies-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-10T12:01:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220610005282\/en\/1482996\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-diagnostics-partnering-terms-and-agreements-report-directory-2015-2022-access-to-3200-deals-signed-by-the-worlds-leading-biopharma-companies-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-diagnostics-partnering-terms-and-agreements-report-directory-2015-2022-access-to-3200-deals-signed-by-the-worlds-leading-biopharma-companies-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Global Diagnostics Partnering Terms and Agreements Report\\\/Directory 2015-2022: Access to 3,200+ Deals Signed by the World&#8217;s Leading Biopharma Companies &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-06-10T12:01:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-diagnostics-partnering-terms-and-agreements-report-directory-2015-2022-access-to-3200-deals-signed-by-the-worlds-leading-biopharma-companies-researchandmarkets-com\\\/\"},\"wordCount\":1057,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-diagnostics-partnering-terms-and-agreements-report-directory-2015-2022-access-to-3200-deals-signed-by-the-worlds-leading-biopharma-companies-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220610005282\\\/en\\\/1482996\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-diagnostics-partnering-terms-and-agreements-report-directory-2015-2022-access-to-3200-deals-signed-by-the-worlds-leading-biopharma-companies-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-diagnostics-partnering-terms-and-agreements-report-directory-2015-2022-access-to-3200-deals-signed-by-the-worlds-leading-biopharma-companies-researchandmarkets-com\\\/\",\"name\":\"Global Diagnostics Partnering Terms and Agreements Report\\\/Directory 2015-2022: Access to 3,200+ Deals Signed by the World's Leading Biopharma Companies - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-diagnostics-partnering-terms-and-agreements-report-directory-2015-2022-access-to-3200-deals-signed-by-the-worlds-leading-biopharma-companies-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-diagnostics-partnering-terms-and-agreements-report-directory-2015-2022-access-to-3200-deals-signed-by-the-worlds-leading-biopharma-companies-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220610005282\\\/en\\\/1482996\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-06-10T12:01:36+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-diagnostics-partnering-terms-and-agreements-report-directory-2015-2022-access-to-3200-deals-signed-by-the-worlds-leading-biopharma-companies-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-diagnostics-partnering-terms-and-agreements-report-directory-2015-2022-access-to-3200-deals-signed-by-the-worlds-leading-biopharma-companies-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-diagnostics-partnering-terms-and-agreements-report-directory-2015-2022-access-to-3200-deals-signed-by-the-worlds-leading-biopharma-companies-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220610005282\\\/en\\\/1482996\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220610005282\\\/en\\\/1482996\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-diagnostics-partnering-terms-and-agreements-report-directory-2015-2022-access-to-3200-deals-signed-by-the-worlds-leading-biopharma-companies-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Global Diagnostics Partnering Terms and Agreements Report\\\/Directory 2015-2022: Access to 3,200+ Deals Signed by the World&#8217;s Leading Biopharma Companies &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Global Diagnostics Partnering Terms and Agreements Report\/Directory 2015-2022: Access to 3,200+ Deals Signed by the World's Leading Biopharma Companies - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/global-diagnostics-partnering-terms-and-agreements-report-directory-2015-2022-access-to-3200-deals-signed-by-the-worlds-leading-biopharma-companies-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Global Diagnostics Partnering Terms and Agreements Report\/Directory 2015-2022: Access to 3,200+ Deals Signed by the World's Leading Biopharma Companies - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Diagnostics Partnering Terms and Agreements 2015-2022&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The Global Diagnostics Partnering Terms and Agreements 2015-2022 report provides comprehensive access to available deals and contract documents for over 3,200 Diagnostics deals. The report provides a detailed understanding and analysis of how and why companies enter Diagnostics partnering ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/global-diagnostics-partnering-terms-and-agreements-report-directory-2015-2022-access-to-3200-deals-signed-by-the-worlds-leading-biopharma-companies-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-06-10T12:01:36+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220610005282\/en\/1482996\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/global-diagnostics-partnering-terms-and-agreements-report-directory-2015-2022-access-to-3200-deals-signed-by-the-worlds-leading-biopharma-companies-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/global-diagnostics-partnering-terms-and-agreements-report-directory-2015-2022-access-to-3200-deals-signed-by-the-worlds-leading-biopharma-companies-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Global Diagnostics Partnering Terms and Agreements Report\/Directory 2015-2022: Access to 3,200+ Deals Signed by the World&#8217;s Leading Biopharma Companies &#8211; ResearchAndMarkets.com","datePublished":"2022-06-10T12:01:36+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-diagnostics-partnering-terms-and-agreements-report-directory-2015-2022-access-to-3200-deals-signed-by-the-worlds-leading-biopharma-companies-researchandmarkets-com\/"},"wordCount":1057,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-diagnostics-partnering-terms-and-agreements-report-directory-2015-2022-access-to-3200-deals-signed-by-the-worlds-leading-biopharma-companies-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220610005282\/en\/1482996\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/global-diagnostics-partnering-terms-and-agreements-report-directory-2015-2022-access-to-3200-deals-signed-by-the-worlds-leading-biopharma-companies-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/global-diagnostics-partnering-terms-and-agreements-report-directory-2015-2022-access-to-3200-deals-signed-by-the-worlds-leading-biopharma-companies-researchandmarkets-com\/","name":"Global Diagnostics Partnering Terms and Agreements Report\/Directory 2015-2022: Access to 3,200+ Deals Signed by the World's Leading Biopharma Companies - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-diagnostics-partnering-terms-and-agreements-report-directory-2015-2022-access-to-3200-deals-signed-by-the-worlds-leading-biopharma-companies-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-diagnostics-partnering-terms-and-agreements-report-directory-2015-2022-access-to-3200-deals-signed-by-the-worlds-leading-biopharma-companies-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220610005282\/en\/1482996\/21\/logo.jpg","datePublished":"2022-06-10T12:01:36+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/global-diagnostics-partnering-terms-and-agreements-report-directory-2015-2022-access-to-3200-deals-signed-by-the-worlds-leading-biopharma-companies-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/global-diagnostics-partnering-terms-and-agreements-report-directory-2015-2022-access-to-3200-deals-signed-by-the-worlds-leading-biopharma-companies-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/global-diagnostics-partnering-terms-and-agreements-report-directory-2015-2022-access-to-3200-deals-signed-by-the-worlds-leading-biopharma-companies-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220610005282\/en\/1482996\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220610005282\/en\/1482996\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/global-diagnostics-partnering-terms-and-agreements-report-directory-2015-2022-access-to-3200-deals-signed-by-the-worlds-leading-biopharma-companies-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Global Diagnostics Partnering Terms and Agreements Report\/Directory 2015-2022: Access to 3,200+ Deals Signed by the World&#8217;s Leading Biopharma Companies &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44948","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=44948"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44948\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=44948"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=44948"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=44948"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}